scholarly article | Q13442814 |
P50 | author | David P. Fairlie | Q40192238 |
Robert C. Reid | Q43043214 | ||
Ronan Kapetanovic | Q56841623 | ||
Kaustav das Gupta | Q86986044 | ||
Abishek Iyer | Q38328402 | ||
Matthew J. Sweet | Q40050893 | ||
P2093 | author name string | Juliana K Ariffin | |
P2860 | cites work | Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells | Q40432586 |
Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay | Q41042385 | ||
Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli | Q41213859 | ||
Mitochondrial control of apoptosis | Q41339880 | ||
Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model | Q41440235 | ||
Spiruchostatin A and B, novel histone deacetylase inhibitors, induce apoptosis through reactive oxygen species-mitochondria pathway in human lymphoma U937 cells | Q42704637 | ||
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection | Q44166565 | ||
Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages | Q44503967 | ||
Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages | Q46250361 | ||
Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function. | Q52523838 | ||
Histone deacetylase inhibitors impair antibacterial defenses of macrophages. | Q54352898 | ||
Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment | Q56879954 | ||
Synergistic effect of colchicine and cytochalasin D on phagocytosis by peritoneal macrophages | Q59054084 | ||
Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis | Q61633704 | ||
Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma | Q83566208 | ||
Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulin | Q84980015 | ||
Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications | Q26853394 | ||
The complete genome sequence of Escherichia coli K-12 | Q27860542 | ||
Lysine acetylation targets protein complexes and co-regulates major cellular functions | Q27860589 | ||
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 | ||
Histone acetylation and deacetylation: importance in inflammatory lung diseases | Q28237379 | ||
Of mice and not men: differences between mouse and human immunology | Q28246229 | ||
Histone deacetylase 7 promotes Toll-like receptor 4-dependent proinflammatory gene expression in macrophages | Q28294510 | ||
Trichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cells | Q28540870 | ||
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer | Q29615649 | ||
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials | Q33243658 | ||
Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum | Q33471440 | ||
TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. | Q34180844 | ||
Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages | Q34263905 | ||
Glycolysis-dependent histone deacetylase 4 degradation regulates inflammatory cytokine production | Q34428648 | ||
A key role for mitochondria in endothelial signaling by plasma cysteine/cystine redox potential. | Q34673234 | ||
Histone deacetylase inhibitors and HIV latency | Q34816844 | ||
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with specia | Q35018415 | ||
Down-regulation of deacetylase HDAC6 inhibits the melanoma cell line A375.S2 growth through ROS-dependent mitochondrial pathway | Q35577980 | ||
Histone deacetylation in epigenetics: an attractive target for anticancer therapy | Q36045533 | ||
Identification of novel modulators of mitochondrial function by a genome-wide RNAi screen in Drosophila melanogaster | Q36259287 | ||
Conservation and divergence in the transcriptional programs of the human and mouse immune systems | Q36637283 | ||
Histone deacetylase inhibitors in inflammatory disease. | Q37438530 | ||
Histone deacetylases as regulators of inflammation and immunity | Q37875468 | ||
HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation. | Q37949185 | ||
HDAC inhibitors in HIV. | Q37956178 | ||
Towards histone deacetylase inhibitors as new antimalarial drugs. | Q38011212 | ||
Towards isozyme-selective HDAC inhibitors for interrogating disease. | Q38029083 | ||
Differences in the repertoire, regulation and function of Toll-like Receptors and inflammasome-forming Nod-like Receptors between human and mouse. | Q38094204 | ||
Murine models of infectious exacerbations of airway inflammation | Q38097163 | ||
Histone deacetylase inhibitors and cell death | Q38217666 | ||
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders | Q38240733 | ||
Depression of mitochondrial metabolism by downregulation of cytoplasmic deacetylase, HDAC6. | Q39364627 | ||
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines | Q39513114 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | reactive oxygen species | Q424361 |
P304 | page(s) | 1521-1529 | |
P577 | publication date | 2015-12-28 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Histone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages | |
P478 | volume | 60 |
Q48939479 | An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice. |
Q41382946 | Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer |
Q55266134 | Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages. |
Q41991798 | Epigenetic regulation in bacterial infections: targeting histone deacetylases |
Q41516139 | Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a |
Q49925707 | For when bacterial infections persist: Toll-like receptor-inducible direct antimicrobial pathways in macrophages. |
Q94526741 | HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment |
Q90705773 | HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis |
Q47242802 | HDAC6 controls innate immune and autophagy responses to TLR-mediated signalling by the intracellular bacteria Listeria monocytogenes. |
Q98465730 | Inhibiting Histone Deacetylases in Human Macrophages Promotes Glycolysis, IL-1β, and T Helper Cell Responses to Mycobacterium tuberculosis |
Q90482206 | Protective Effect of Tubastatin A in CLP-Induced Lethal Sepsis |
Q40355358 | Small GTPase Rab8a-recruited Phosphatidylinositol 3-Kinase γ Regulates Signaling and Cytokine Outputs from Endosomal Toll-like Receptors. |
Q57712790 | Targeting transcription factor lysine acetylation in inflammatory airway diseases |
Q38926320 | The therapeutic potential of epigenetic manipulation during infectious diseases. |
Q94461793 | Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab |
Search more.